Previous close | 22.84 |
Open | 23.50 |
Bid | 24.20 x 100 |
Ask | 24.37 x 100 |
Day's range | 22.77 - 25.91 |
52-week range | 9.26 - 26.70 |
Volume | |
Avg. volume | 234,025 |
Market cap | 671.194M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Comprehensive Analysis of Castle Biosciences' First Quarter Financial Performance
Castle Biosciences (CSTL) delivered earnings and revenue surprises of 75.68% and 6.78%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...